<DOC>
	<DOC>NCT01998204</DOC>
	<brief_summary>Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. The investigators clinical experience showed a trend of delayed emergence among patients undergoing deep brain stimulator (DBS) implantation and pulse generator placement under general anesthesia. Abnormal pharmacodynamics might be present among these patients, which had never been investigated.</brief_summary>
	<brief_title>Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Patients with Parkinson's disease undergoing deep brain stimulator implantation and pulse generator placement under general anesthesia nonParkinsonian patients without Parkinson's disease undergoing intracranial surgery under general anesthesia ASA score higher than Class III predicted difficult airway hearing impairment inability to corporate with instruction alcohol or drug abuser patients refusing to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Parkinson's disease</keyword>
	<keyword>propofol</keyword>
	<keyword>deep brain stimulator</keyword>
</DOC>